| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 64 |
| 1 | DUPILUMAB | 61 |
| 2 | MEPOLIZUMAB | 59 |
| 3 | PREDNISOLONE | 39 |
| 4 | PREDNISOLONE ORAL | 39 |
| 5 | PREDNISOLONE ORAL SOLUTION | 39 |
| 6 | OMALIZUMAB | 30 |
| 7 | ALBUTEROL SULFATE | 28 |
| 8 | MONTELUKAST SODIUM | 26 |
| 9 | MONTELUKAST | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 1 | 0.0079 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| 2 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 1 | 0.0067 |
| 3 | USTEKINUMAB-TTWE | 1 | 0.0052 |
| 4 | TITANIUM DIOXIDE | 1 | 0.0041 |
| 5 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 6 | PRAZIQUANTEL | 1 | 0.0033 |
| 7 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 1 | 0.0022 |
| 8 | DEFLAZACORT | 5 | 0.0019 |
| 9 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 3 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 60 | 0.0872 |
| 1 | Antiparasitic [EPC] | 5 | 0.0011 |
| 2 | Pediculicide [EPC] | 5 | 0.0011 |
| 3 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 4 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 5 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 6 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 7 | Anthelmintic [EPC] | 2 | 0.0007 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 9 | Interferon alfa-2b [EPC] | 1 | 0.0005 |